Literature DB >> 1078771

Multiple primary malignant neoplasms. A search for an immunogenetic basis.

A L Dellon, P B Chretien, C Potvin, G N Rogentine.   

Abstract

The occurrence of multiple primary malignant neoplasms in single individuals is well documented. Although many hypotheses have been advanced to explain this occurrence, there has been no study to determine if a presumed "increased susceptibility to cancer" has an immunogenetic basis. We evaluated the cellular immunity and histocompatibility antigens of 42 patients who had had from two to four multiple primary malignant neoplasms. We failed to demonstrate a preexisting impairment of immunocompetence or abnormal HL-A antigen frequencies in these patients. The occurrence of multiple primary malignant neoplasms in related tissues, eg, lung/larynx/oral cavity, and the occurrence of successive primary malignant neoplasms at a time interval consistent with the patient's being cured of preceding malignant neoplasms suggest that multiple primary malignant neoplasms result from repetitive induction by the same or similar etiologic factors in patients who are cured after treatment of the first malignant neoplasm.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078771     DOI: 10.1001/archsurg.1975.01360080022003

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Quadruple cancer including bilateral breasts, Vater's papilla, and urinary bladder: report of a case.

Authors:  H Nakayama; H Masuda; W Ugajin; Y Nakamura; K Akiyama; K Suzuki; S Amano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Multiple primary malignant neoplasia in three members of a family.

Authors:  G S Kenyon
Journal:  J R Soc Med       Date:  1981-08       Impact factor: 18.000

3.  Effect of a 12-week walking exercise program on body composition and immune cell count in patients with breast cancer who are undergoing chemotherapy.

Authors:  Ji Jeong Kim; Yun A Shin; Min Hwa Suk
Journal:  J Exerc Nutrition Biochem       Date:  2015-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.